Compare BUDA & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BUDA | BHST |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.0M | 117.2M |
| IPO Year | 2026 | N/A |
| Metric | BUDA | BHST |
|---|---|---|
| Price | $9.10 | $4.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | ★ 42.1K | 38.1K |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | $12,486,000.00 | ★ $32,720,000.00 |
| Revenue This Year | N/A | $116.40 |
| Revenue Next Year | N/A | $55.91 |
| P/E Ratio | $25.24 | ★ N/A |
| Revenue Growth | 33.11 | ★ 45.88 |
| 52 Week Low | $6.85 | $4.65 |
| 52 Week High | $12.00 | $12.80 |
| Indicator | BUDA | BHST |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.79 |
| Support Level | N/A | $4.82 |
| Resistance Level | N/A | $4.84 |
| Average True Range (ATR) | 0.00 | 0.40 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 7.33 |
Buda Juice Inc operates in a competitive beverage industry, focused on fresh, cold-crafted juice production for business-to-business (B2B) distribution. The Company mostly utilizes third-party delivery systems and operates within the State of Texas serving large, national chain grocery stores. It is pioneering a new category in beverages-UltraFresh juice-offering cold-crafted citrus-based drinks that are never pasteurized, never HPP- processed, never UV- treated and always cold.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.